about
Rosai-Dorfman disease: a previously unreported association with sickle cell diseaseAssociations between environmental factors and hospital admissions for sickle cell disease.The role of religious leaders and faith organisations in haemoglobinopathies: a reviewSickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype.Obstructive sleep apnea and sickle cell anemia.Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia.Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell diseaseInfection in sickle cell disease: a review.Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trialAssessing the quality of life of children with sickle cell anaemia using self-, parent-proxy, and health care professional-proxy reports.Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.A case of familial unilateral tight shoe.Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.Wheezing is common in children with sickle cell disease when compared with controls.Factors predicting future ACS episodes in children with sickle cell anemiaProceedings of a Sickle Cell Disease Ontology workshop - Towards the first comprehensive ontology for Sickle Cell DiseaseNocturnal oxygen desaturation and disordered sleep as a potential factor in executive dysfunction in sickle cell anemiaProblems with implementing a standardised transcranial Doppler screening programme: impact of instrumentation variation on STOP classification.Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature.Juvenile polymyositis with unremitting pain and progressive loss of motor and bulbar function on a background of sickle cell disease.Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.Cerebral microhaemorrhages secondary to fat embolus syndrome in sickle cell disease.Rickets and tracheobronchomalacia.Pandemic influenza A (H1N1) virus infections in children with sickle cell disease.A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.l-selectin gene polymorphisms and complications of sickle cell disease.The measurement of urinary hydroxyurea in sickle cell anaemia.Real-time dose adjustment using point-of-care platelet reactivity testing in a double-blind study of prasugrel in children with sickle cell anaemia.Sickle Cell DiseasePrevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol fEuropean migration crises: The role of national hemoglobinopathy registries in improving patient access to careHydroxycarbamide use in young children with sickle-cell anaemiaLung function impairment in pediatric patients with sickle cell anemia from Nigeria is associated with low steady state hemoglobinIndex of Pain Experience in Sickle Cell Anaemia (IPESCA): development from daily pain diaries and initial findings from use with children and adults with sickle cell anaemiaAn Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective
P50
Q33281067-78D76FEB-D548-48FF-8D0B-7A820637B133Q33469363-50D4D1CF-3DFC-48D0-950E-A5F29194A1C1Q33493611-B7FE94C0-290F-46ED-A763-17F649B45E99Q33974050-A5834130-666A-44AB-9CC9-BFBF425DB366Q34296032-C9CC1C20-A540-43BD-BE01-35C868AA2B89Q34330904-67861A6E-EEB7-440B-8C19-1F7BDB28D488Q34398287-E6198596-077E-4D1B-B7E6-D0EE746F03BFQ34557931-B3423DC2-B8FA-4698-A26E-C549B7A92556Q34608492-52464028-C47A-4F78-9008-4BABB4815F09Q34665167-AE50EDB7-A23E-4699-98DB-98A51167491EQ35007607-C897970D-2456-4D8F-9694-ADBED5CC5FDAQ35007863-72FE5CB4-6520-47E0-8CB7-758CF754F3B1Q35155761-16BD72CB-A723-4C56-A361-7F78CD502B48Q35206809-D20A3FB3-505E-4E27-AC95-7AF1C3257986Q35909642-292291EE-E1F6-4B94-9187-357B5216D22CQ36121641-51CA51E5-AB8B-436E-AE29-54A3DEA251FCQ36843672-A6710DFE-7B6A-4DA9-B48B-E3890898EEE9Q36899803-1A821A12-F8B7-48AD-8262-533BBFDE8EC3Q36900201-F9184965-2A18-403C-8D00-EF82DC88B262Q37014532-5E95C463-EDF2-4F2A-A0B1-1A77DF3D81E0Q37059565-DF779452-693E-4103-99F2-CFE3DEA183C5Q37946316-A0125B55-D7C3-4FDE-B2AC-FB6B1C60DCC7Q38553894-39AD086E-C9F6-4D19-A3D5-E449150B771CQ39270214-0EBA070E-0E2E-4913-A6B0-ACE74FC48418Q40526934-C619AA65-CAF9-4922-B2C1-8317FE678404Q41382795-BF7856AC-3F20-421A-943C-5738AE56E8C4Q41547463-7C4A796A-F367-4AF7-B99B-18782D53F07BQ41835391-A776542D-B51C-48AF-B237-50AE6ADB80C1Q43124610-06BD6F24-7820-464A-9EF6-150E8ACE95D1Q46178951-5A3032B9-9B2D-43DE-A2BD-322FCEE5EB2EQ46456121-4ECA2F39-7449-471E-8DAC-1F8BBCAFC209Q46569740-BD0E40F9-784C-4C77-91BC-B6ECACD9F47DQ51023057-50781350-1143-4240-AAA2-9A80BE44CC2BQ57193464-DA557BDE-55E2-4143-A781-0A9CB38F2D32Q58319619-3D3674DA-111C-46AF-9F8B-E460FAC425AEQ61860561-7A571738-0973-42DB-8D89-8994D649D57CQ61860590-4730FF45-74AD-40F1-94D0-322311ECD8A7Q90403123-255EAAFE-3BA8-4C76-9C7D-82823A1AB1CDQ92144604-CFF9FDE2-6AA0-4E52-9262-B530898312B8Q92258535-2E77FEF0-9D2D-4AC6-BF4A-AB173EC6E7CC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Baba Inusa
@ast
Baba Inusa
@en
Baba Inusa
@es
Baba Inusa
@nl
Baba Inusa
@sl
type
label
Baba Inusa
@ast
Baba Inusa
@en
Baba Inusa
@es
Baba Inusa
@nl
Baba Inusa
@sl
prefLabel
Baba Inusa
@ast
Baba Inusa
@en
Baba Inusa
@es
Baba Inusa
@nl
Baba Inusa
@sl
P106
P21
P31
P496
0000-0003-2643-765X